Heart Failure Research for Hospitalized Patients

Acute Heart Failure With Preserved Ejection Fraction - COngestion Discharge Evaluation

Recruiting N/A Interventional Study
Acute Heart Failure
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
170 (estimated)
Sponsor
Central Hospital, Nancy, France · Other
Who this trial is looking for

This trial is looking for patients who have been hospitalized for heart failure with preserved heart function. Participants will help researchers identify signs that may predict future health risks after leaving the hospital.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been hospitalized for acute heart failure.
  • I have preserved ejection fraction (FE ≥ 50%).
  • I am being considered ready for discharge from the hospital.
  • I am at least 18 years old.
  • I have received information about the study and signed consent.
  • I am covered by a social security scheme.

You may not be able to join if

  • My life expectancy is 3 months or less due to another illness.
  • I am currently on dialysis or have very poor kidney function.
  • I have had lung surgery that involved removing part of my lung.
  • I have severe lung disease that prevents lung ultrasound imaging.
  • I am pregnant, giving birth, or breastfeeding.
  • I am under legal protection and cannot make my own decisions.
  • I am unable to give consent.
  • I am in a judicial or administrative detention.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The AHF-CODE preserved study is a prospective, non-randomized, monocenter study performed in patients with heart failure with preserved ejection fraction admitted for worsening heart failure. The main objective of the AHF-CODE preserved study is to identify congestion markers (clinical, biological and ultrasound) at the end of hospitalization for acute heart failure that are associated with the r…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients hospitalised for acute heart failure. * Patient with preserved ejection fraction (FE ≥ 50%). * Patients considered clinically discharging from hospitalisation for acute heart failure. * Age ≥18 years * Patients having received complete information regarding the study …
Contacts

Nicolas GIRERD, MD,PhD

+ 33 3 83 15 73 22

n.girerd@chru-nancy.fr

CONTACT